26
Participants
Start Date
February 29, 2008
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
quetiapine XR
Subjects will receive daily dosing at night, with a flexible dosing schedule, 50-400 mg.
placebo
Subjects will receive daily dosing at night with caplets matching the appearance of the active drug. However, caplets will not contain any active medication.
University Hospital Outpatient Center, Psychiatry, Indianapolis
Collaborators (1)
AstraZeneca
INDUSTRY
Indiana University
OTHER